medigraphic.com
Instituto Nacional de Neurología y Neurocirugía

2009, Number 1

<< Back

Arch Neurocien 2009; 14 (1)

Bony description postmortem of an anencephaly

Alonso GJC, Álvarez AB, León CGD, González RS

Language: Spanish
References: 34
Page: 78-82
PDF size: 239.26 Kb.


ABSTRACT

The defects of the neural tube represent the greater group of malformations of central nervous system (SNC) caused by anomalies in the closing, whose etiologic is been from the interaction of genetic and environmental factors. One of the main ones that we can find is the bifid thorn that includes understands meningocele, myelomeningocele, and anencephaly. She is one of the most common anomalies; all is characterized by alterations that affect the neural weave, meninges and soft bone or weaves that are on them. We presented displayed a case of a bony description of a product of between 37 and 38 weeks of gestational age (SDG) by somatometry (chimney, radius, femur, tibia), which presents displays the own alterations of this suffering.


REFERENCES

  1. Stanley L, Robbins. Patología humana, 7a. Edición, Editorial Elsevier España, 2004.

  2. Age Markers in the human Sketetum Ed. ted. Dy Merhmet yasar iscan, Ph.D. DBFA, Department of Anthropology Florida Atlantic University Boca ratun, Florida.

  3. Carlson, Bruce M, Human Embryology and developmental biology Ed. Mosby, 1994, EE.UU.

  4. Langman. Embriología Médica con orientación clínica, 8 ed. Edit. Panamericana, México 2001.

  5. Alajem S. Atlas de perinatologia. Edición revolucionaria. Editorial Cientifico Técnica, 1981.

  6. Nielsen LA, Maroun LL, Broholm H, Laursen H, Graem N. Neural tube defects and associated anomalies in a fetal and perinatal autopsy series. APMIS 2006;114 (4): 239-46.

  7. O’Rahilly R, Müller F. The development of the neural crest in the human, J Anat 2007; 211(3):335-51.

  8. Antonsson P, Sundberg A, Kublickas M, Pilo C, Ghazi S, Westgren M, et al. Correlation between ultrasound and autopsy findings after 2nd trimester terminations of pregnancy. J Perinat Med 2008; 36 (1): 59-69.

  9. Arredondo-de Arreola G, Rodríguez-Bonito R. Malformaciones congénitas en recién nacidos vivos. Bol Med Hosp Infant Mex 1990;47: 822-7.

  10. Jiménez-Balderas E, Salamanca-Gómez F. Estudio de malformaciones congénitas en 105,825 nacimientos consecutivos. Bol Med Hosp Infant Mex 1985;42:744-8.

  11. Hernández-Arriaga JL, Cortés-Gallo G. Incidencia de malformaciones congénitas externas en el Hospital de Ginecopediatría No. 48 en León, Guanajuato. Bol Med Hosp Infant Mex 1991;48:717-21.

  12. Cedeño-Rincón R, León A, Romero R. Epidemiología de las malformaciones congénitas externas en una maternidad de Venezuela. Bol Med Hosp Infant Mex 1996;53:117-22.

  13. Mutchinick O, Lisker R. Programa mexicano de “Registro y vigilancia epidemiológica de malformaciones congénitas externas”. Salud Publica Mex 1988;30:88-100.

  14. García-Morales M, Limón-Luque LM. Uso periconcepcional de ácido fólico en la prevención de defectos del tubo neural: conceptos actuales. Ginecol Obstet Mex 1996;64:418-21.

  15. Walss-Rodríguez R, Reyes-Garnica A. Epidemiología de los defectos congénitos del tubo neural en la ciudad de Torreón, Coahuila. Rev Med Inst Mex Seguro Soc 1990;28:265-8.

  16. Mutchinick O. Epidemiología de las malformaciones congénitas. Gac Med Mex 1996;131:152-60.

  17. Canún-Serrano S, Saavedra-Ontiveros D. Malformaciones congénitas en diferentes etapas del desarrollo intrauterino. Ginecol Obstet Mex 1990;58:1-4.

  18. Rodríguez-Morán M, Guerrero-Romero JF. Prevalencia de malformaciones congénitas en una población socioeconómica baja. Rev Invest Med SS IMSS 1996;1:16-23. 19. Pietrzik KF, Thorand B. Folate economy in pregnancy. Nutrition 1997;13:975-7.

  19. Milunsky A, Jick H, Jick S. Multivitamin/folic acid supplementation in early pregnancy reduces the prevalence of neural tube defects. JAMA 1989;262:2847-52.

  20. 21.Willett W. Folio acid and neural tube defect: Can’t we come to closure? Am J Public Health 1992;82:666-8.

  21. Milis JL, Rhoads G, Simpson JL. The absence of a relation between the periconceptional use of vitamins and neural-tube defects. N Engl J Med 1989;321:430-5.

  22. Daly S, Milis J, Molloy A. Minimum effective dose of folic acid for food fortification to prevent neural-tube defects. Lancet 1997;350:1666-9.

  23. Breown J, Jacobs D. Predictors of red cell folate level in women attempting pregnancy. JAMA 1997;277:545-52.

  24. Daly LE, Kirke PN, Molloy A. Folate levels and neural tube defects. JAMA 1995;274:1698-702.

  25. Milis J, Rhoads G, Simpson J. Vitamins during pregnancy and neural tube defects. JAMA 1990;263:2747-8.

  26. Medical Research Council Vitamin Study Research Group. Prevention of neural tube defects; results of the medical research council vitamin study. Lancet 1991;338:131-7.

  27. Eskes TK. Folates and the fetus. Eur J Obstet Gynecol Reprod Biol 1997;71:105-11.

  28. Eskes TK, Steegers-Theunissen RP. Primary prevention of neural-tube defects with folic acid. Eur J Obstet Gynecol Reprod Biol 1994;53:147-52.

  29. Eskes TK. Possible basis for primary prevention of birth defects with folio acid. Fetal Diagn Ther 1994;9:149-54.

  30. Wigertz K, Svensson UK, Jagerstad M. Folate and folate-binding protein content in dairy products. J Dairy Res 1997;64:239-52.

  31. Muñoz Juárez Sergio, Ortíz Espinosa Rosa María. Muerte por anencefalia, variables asociadas a los padres y peso al nacer. Rev Mex Pediatr 2005; 72(5): 226-9.

  32. http://electroneubio.secyt.gov.ar/Anencephaly.htm

  33. http://www. iq b.es/neurolog ia/atlas/malformaciones/ anencefalia01.htm

  34. http://www.dgepi.salud.gob.mx/diveent/DTN.htm




2020     |     www.medigraphic.com